Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shape decrease » shape increases (Expand Search), step decrease (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shape decrease » shape increases (Expand Search), step decrease (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
-
2341
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2342
-
2343
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2344
-
2345
-
2346
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2347
-
2348
-
2349
-
2350
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2351
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2352
-
2353
-
2354
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2355
-
2356
-
2357
-
2358
-
2359
-
2360